Merus N.V. financial data

Symbol
MRUS on Nasdaq
Industry
Pharmaceutical Preparations
Location
Yalelaan 62, 3584 Cm Utrecht, Netherlands
State of incorporation
Netherlands
Fiscal year end
December 31
Former names
Merus B.V. (to 5/23/2016)
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 730 % +65.6%
Debt-to-equity 24.8 % -39.3%
Return On Equity -45.4 % +28.4%
Return On Assets -36.4 % +19.2%
Operating Margin -643 % -80.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.5M shares +18.6%
Common Stock, Shares, Outstanding 68.4M shares +18.5%
Entity Public Float 1.3B USD +26.1%
Common Stock, Value, Issued 6.92M USD +17.8%
Weighted Average Number of Shares Outstanding, Basic 68.3M shares +26.7%
Weighted Average Number of Shares Outstanding, Diluted 68.3M shares +26.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 35.9M USD -21.3%
Research and Development Expense 192M USD +28.6%
General and Administrative Expense 75.3M USD +26.9%
Operating Income (Loss) -231M USD -42%
Nonoperating Income (Expense) -6.17M USD +46.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -237M USD -36.1%
Income Tax Expense (Benefit) 7.43M USD +192%
Net Income (Loss) Attributable to Parent -245M USD -38.4%
Earnings Per Share, Basic -3.91 USD/shares -3.44%
Earnings Per Share, Diluted -3.91 USD/shares -3.44%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 433M USD +79%
Marketable Securities, Current 199M USD +35.8%
Cash, Cash Equivalents, and Short-term Investments 287M USD -25.2%
Accounts Receivable, after Allowance for Credit Loss, Current 1.13M USD -67%
Other Assets, Current 2.7M USD +93%
Assets, Current 666M USD +64.6%
Deferred Income Tax Assets, Net 838K USD +19.4%
Property, Plant and Equipment, Net 12.1M USD -0.25%
Operating Lease, Right-of-Use Asset 10.3M USD -8.93%
Other Assets, Noncurrent 2.63M USD -36.3%
Assets 845M USD +71.6%
Accounts Payable, Current 6.19M USD +60.9%
Employee-related Liabilities, Current 7.16M USD +39.2%
Accrued Liabilities, Current 38.5M USD +8.13%
Liabilities, Current 80.1M USD +24.5%
Operating Lease, Liability, Noncurrent 9.28M USD -11.6%
Liabilities 141M USD +43.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.12M USD +81%
Retained Earnings (Accumulated Deficit) -937M USD -35.3%
Stockholders' Equity Attributable to Parent 703M USD +78.8%
Liabilities and Equity 845M USD +71.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -44.4M USD -20.8%
Net Cash Provided by (Used in) Financing Activities 30.2M USD +13797%
Net Cash Provided by (Used in) Investing Activities -12.1M USD -43.7%
Common Stock, Shares Authorized 105M shares +55.6%
Common Stock, Shares, Issued 68.4M shares +18.5%
Common Stock, Par or Stated Value Per Share 0.09 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -26.1M USD +42.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 434M USD +78.8%
Deferred Tax Assets, Valuation Allowance 173M USD +33.4%
Deferred Tax Assets, Gross 177M USD +31.1%
Operating Lease, Liability 12.2M USD -9.74%
Payments to Acquire Property, Plant, and Equipment 63K USD -98.3%
Lessee, Operating Lease, Liability, to be Paid 14.4M USD +14343%
Property, Plant and Equipment, Gross 19.9M USD +14.2%
Operating Lease, Liability, Current 1.76M USD +9.65%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.22M USD +3.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.21M USD -2.99%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -135K USD +49.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.28M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.79M USD -17.7%
Deferred Tax Assets, Operating Loss Carryforwards 162M USD +46.3%
Deferred Federal Income Tax Expense (Benefit) -95K USD +49.5%
Current Income Tax Expense (Benefit) 7.56M USD +169%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.56M USD -9.71%
Operating Lease, Payments 2.18M USD -15.3%
Current State and Local Tax Expense (Benefit) 2.12M USD +155%
Current Federal Tax Expense (Benefit) 5.45M USD +176%
Amortization of Intangible Assets 46K USD -14.8%
Depreciation, Depletion and Amortization 561K USD +5.06%
Deferred Tax Assets, Net of Valuation Allowance 4.2M USD -22.3%
Share-based Payment Arrangement, Expense 36.7M USD +43.7%
Deferred State and Local Income Tax Expense (Benefit) -40K USD +48.1%